Moreover, immunohistochemistry (IHC) staining of primary and metastatic tumors showed that PTK6 reversed the effects of PSPC1 on downregulating E-cadherin and upregulating vimentin, β-catenin, c-Myc and Wnt3a. Here, PSPC1 is linked to metastatic neoplasm.